Stergiopoulou, D.; Markou, A.; Giannopoulou, L.; Buderath, P.; Balgkouranidou, I.; Xenidis, N.; Kakolyris, S.; Kasimir-Bauer, S.; Lianidou, E.
Detection of ESR1 Mutations in Primary Tumors and Plasma Cell-Free DNA in High-Grade Serous Ovarian Carcinoma Patients. Cancers 2022, 14, 3790.
https://doi.org/10.3390/cancers14153790
AMA Style
Stergiopoulou D, Markou A, Giannopoulou L, Buderath P, Balgkouranidou I, Xenidis N, Kakolyris S, Kasimir-Bauer S, Lianidou E.
Detection of ESR1 Mutations in Primary Tumors and Plasma Cell-Free DNA in High-Grade Serous Ovarian Carcinoma Patients. Cancers. 2022; 14(15):3790.
https://doi.org/10.3390/cancers14153790
Chicago/Turabian Style
Stergiopoulou, Dimitra, Athina Markou, Lydia Giannopoulou, Paul Buderath, Ioanna Balgkouranidou, Nikolaos Xenidis, Stylianos Kakolyris, Sabine Kasimir-Bauer, and Evi Lianidou.
2022. "Detection of ESR1 Mutations in Primary Tumors and Plasma Cell-Free DNA in High-Grade Serous Ovarian Carcinoma Patients" Cancers 14, no. 15: 3790.
https://doi.org/10.3390/cancers14153790
APA Style
Stergiopoulou, D., Markou, A., Giannopoulou, L., Buderath, P., Balgkouranidou, I., Xenidis, N., Kakolyris, S., Kasimir-Bauer, S., & Lianidou, E.
(2022). Detection of ESR1 Mutations in Primary Tumors and Plasma Cell-Free DNA in High-Grade Serous Ovarian Carcinoma Patients. Cancers, 14(15), 3790.
https://doi.org/10.3390/cancers14153790
